The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
Open accessAbstract
Human C5a, a complement-derived anaphylatoxin, is a potent mediator of human leukocyte chemotaxis. Using a homogeneous preparation of C5a that was 125I-labeled, we have demonstrated the presence of a specific cellular receptor for this glycoprotein on intact human polymorphonuclear leukocytes. Cellular uptake of the radiolabeled ligand occurred rapidly and the rate of dissociation was extremely slow. Cellular binding was saturable with respect to 125I-labeled C5a, and half-saturation occurred at a concentration of 3-7 X 10(-9) M. The number of C5a binding sites per cell was estimated as 1-3 X 10(5). The ligand (C5a) displays specific structural features that are required for binding because analogs of C5a such as C5ades Arg or a yeast carboxypeptidase-digested C5a derivative C5a-(I-69) inhibited the binding but C3a anaphylatoxin, which resembles C5a chemically, did not. Both C5a-mediated leukocyte chemotaxis and C5a-induced lysosomal enzyme release from cytochalasin B-treated cells closely paralleled uptake of the ligand, clearly indicating that it is a receptor-C5a interaction that leads to stimulation of these cellular responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolton, A. E., & Hunter, W. M. (1973) · Biochemical Journal · doi:10.1042/bj1330529 · Cited by 3,254
Nelson, R. D., Quie, P. G., & Simmons, R. L. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.115.6.1650 · Cited by 1,170
Craddock, P. R., Hammerschmidt, D., White, J. G., Dalmosso, A. P., & Jacob, H. S. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108763 · Cited by 685
Cuatrecasas, P. (1974) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.43.070174.001125 · Cited by 639
Fernández, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · PubMed · Cited by 567
Self-citationBrittinger, G., Hirschhorn, R., Douglas, S. D., & Weissmann, G. (1968) · The Journal of Cell Biology · doi:10.1083/jcb.37.2.394 · Cited by 233
Fernández, H. N., & Hugli, T. E. (1976) · PubMed · Cited by 185
Self-citationHuman anaphylatoxin (C3a) from the third component of complement. Primary structure.
Hugli, T. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40758-8 · Cited by 164
Self-citationRole of a peptidase in phagocyte chemotaxis.
Aswanikumar, S., Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2439 · Cited by 81
Cited by
Complement and the damaging effects of cardiopulmonary bypass
Kirklin, J. K., Westaby, S., Blackstone, E. H., Kirklin, J. W., Chenoweth, D. E., & Pacifico, A. D. (1983) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39061-0 · Cited by 1,325
Self-citationChenoweth, D. E., Cooper, S. W., Hugli, T. E., Stewart, R. W., Blackstone, E. H., & Kirklin, J. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198102263040901 · Cited by 1,146
Self-citationInflammatory response to cardiopulmonary bypass
Butler, J., Rocker, G. M., & Westaby, S. (1993) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(93)91048-r · Cited by 1,033
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
The Pathophysiology of Aortic Cross-clamping and Unclamping
Gelman, S. (1995) · Anesthesiology · doi:10.1097/00000542-199504000-00027 · Cited by 603
Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent
de Haas, C. J. C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J. B., Heezius, E. C. J. M., Poppelier, M. J. J. G., Van Kessel, K. P. M., & van Strijp, J. A. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031636 · Cited by 471
The Biology and Detection of Immune Complexes
Theofilopoulos, A. N., & Dixon, F. J. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60800-7 · Cited by 467
The dark side of C5a in sepsis
Ward, P. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1269 · Cited by 422
Molecular and Cellular Mechanisms of Leukocyte Chemotaxis
Snyderman, R., & Goetzl, E. J. (1981) · Science · doi:10.1126/science.6266014 · Cited by 415
Mechanisms of Muscle Injury, Repair, and Regeneration
Tidball, J. G. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100092 · Cited by 390
The Inflammatory Response to Cardiopulmonary Bypass: Part 1—Mechanisms of Pathogenesis
Warren, O. J., Smith, A. J., Alexiou, C., Rogers, P. L. B., Jawad, N., Vincent, C., Darzi, A. W., & Athanasiou, T. (2009) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2008.08.007 · Cited by 363
Complement Activation and Hypersensitivity Reactions to Dialysis Membranes
Hakim, R. M., Breillatt, J., Lazarus, J. M., & Port, F. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410043111403 · Cited by 342
THE ROLE OF THE COMPLEMENT SYSTEM IN ISCHEMIA-REPERFUSION INJURY
Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Granger, D. N., & Taylor, S. M. (2004) · Shock · doi:10.1097/00024382-200405000-00002 · Cited by 327
The complement system: History, pathways, cascade and inhibitors
Nesargikar, P., Spiller, B., & Chavez, R. (2012) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.2.2012.2.2 · Cited by 324
Boulay, F., Tardif, M., Brouchon, L., & Vignais, P. (1990) · Biochemistry · doi:10.1021/bi00502a016 · Cited by 322
Complement Ligand-Receptor Interactions that Mediate Biological Responses
Fearon, D. T., & Wong, W. W. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001331 · Cited by 290
Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil function
Webster, R. O., Hong, S. R., Johnston, R. B., & Henson, P. M. (1980) · Immunopharmacology · doi:10.1016/0162-3109(80)90050-8 · Cited by 261
Structure and function of the anaphylatoxins
Hugh, T. E. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893020 · Cited by 259
Complement receptors and their role in leukocyte recruitment and phagocytosis
Vandendriessche, S., Cambier, S., Proost, P., & Marques, P. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.624025 · Cited by 178
Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
Asimakopoulos, G., & Taylor, K. M. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00727-9 · Cited by 173
Conroy, A., Serghides, L., Finney, C., Owino, S. O., Kumar, S., Gowda, D. C., Liles, W. C., Moore, J. M., & Kain, K. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004953 · Cited by 81
C5a anaphylatoxin and its role in critical illness-induced organ dysfunction
Wood, A. J. T., Vassallo, A., Summers, C., Chilvers, E. R., & Conway‐Morris, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13028 · Cited by 45
“Firstly, C5a is cleared by receptor‐ mediated internalisation by immune cells in vascular organs such as the lung, spleen, liver and kidney.(13,14) Furthermore, removal of the C‐terminal arginine residue (desargination) from the C5a molecule(15) by serum carboxypeptidases N, B or R yields C5ades-arg, which exerts less…”
Background
Metadata
- Authors
- Chenoweth, D. E., & Hugli, T. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1978-08
- Volume
- 75
- Issue
- 8
- Pages
- 3943-3947
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2062208099
- Cited by
- 509
- References
- 9
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.